D-Amphetamine Causes Dual Actions on Catecholamine Release from the Rat Adrenal Medulla
![]() |
Lim, Geon-Han
(Departments of Neurology, College of Medicine, Chosun University)
Na, Gwang-Moon (Departments of Pharmacology, College of Medicine, Chosun University) Min, Seon-Young (Departments of Pharmacology, College of Medicine, Chosun University) Seo, Yoo-Seok (Departments of Pharmacology, College of Medicine, Chosun University) Park, Chan-Won (Departments of Pharmacology, College of Medicine, Chosun University) Lim, Dong-Yoon (Departments of Pharmacology, College of Medicine, Chosun University) |
1 | Seiden LS, Sabol KE, Ricaurte GA. D-amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 33: 639-677, 1993 DOI ScienceOn |
2 | Wada Y, Satoh K, Taira N. Cardiovascular profile of Bay-K-8644, a presumed calcium channel activator in the dog. Naunyn- Schmiedebergs Arch Pharmacol 328: 382-387, 1985 DOI ScienceOn |
3 | Wakade AR. Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland. J Physiol 313: 463-480, 1981 DOI PUBMED |
4 | Akaike A, Mine Y, Sasa M, Takaori S. Voltage and current clamp studies of muscarinic and nicotinic excitation of the rat adrenal chromaffin cells. J Pharmacol Expt Ther 255: 333-339, 1990 |
5 | Anton AH, Sayre DF. A study of the factors affecting the aluminum oxide trihydroxy indole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 138: 360-375, 1962 PUBMED |
6 |
Catterall WA. Structure and regulation of voltage-gated |
7 | Cheek TR, Burgoyne RD. Cyclic AMP inhibits both nicotine-induced actin disassembly and catecholamine secretion from bovine adrenal chromaffin cells. J Biol Chem 262:11663-11666, 1987 PUBMED |
8 | Gandia L, Borges R, Albillos A, Garcia AG. Multiple calcium channel subtypes in isolated rat chromaffin cells. Pflugers Arch 430: 55-63, 1995 DOI ScienceOn |
9 |
Goeger DE, Riley RT. Interaction of cyclopiazonic acid with rat skeletal muscle sarcoplasmic reticulum vesicles. Effect on |
10 | Hernandez-Guijo JM, Gandia L, de Pascual R, Garcia AG. Differential effects of the neuroprotectant lubeluzole on bovine and mouse chromaffin cell calcium channel subtypes. Br J Pharmacol 122: 275-285, 1997 DOI ScienceOn |
11 | Inoue M, Kuriyama H. Muscarinic receptor is coupled with a cation channel through a GTP-binding protein in guinea-pig chromaffin cells. J Physiol (Lond) 436: 511-529, 1991 DOI PUBMED |
12 | Ladona MG, Aunis D, Gandia AG, Garcia AG. Dihydropyridine modulation of the chromaffin cell secretory response. J Neurochemstry 48: 483-490, 1987 DOI |
13 |
Kim KT, Westhead EW. Cellular responses to |
14 | Knepper SM, Grunewald GL, Rutledge CO. Inhibition of norepinephrine transport into synaptic vesicles by d-amphetamine analogs. J Pharmacol Exp Ther 247: 487-494, 1988 PUBMED |
15 | Kujacic M, Carlsson A. Influence of GBR 12909 and d-amphetamine on indices of catecholamine synthesis and release in rat adrenal glands. Neuropharmacology 33: 983-987, 1994 DOI ScienceOn |
16 | Laruelle M, Abi-Dargham A, van Dyck C, Gil R, D'Souza DC, Krystal J, Seibyl J, Baldwin R, Innis R. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [123]beta-CIT. Biol Psychiatry 47: 371-379, 2000 DOI ScienceOn |
17 | Pifl C, Drobny H, Reither H, Hornykiewicz O, Singer EA. Mechanism of the dopamine-releasing actions of d-amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol Pharmacol 47: 368-373, 1995 PUBMED |
18 | Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223, 1987 DOI PUBMED |
19 |
Schramm M, Thomas G, Towart R, Franckowiak G. Novel dihydropyridines with positive inotropic action through activation of |
20 | Tallarida RJ, Murray RB. Manual of pharmacologic calculation with computer programs. 2nd ed. Speringer-Verlag, New York, p 132, 1987 |
21 |
Uceda G, Artalejo AR, de la Fuente MT, Lopez MG, Albillos A, Michelena P, Garcia AG, Montiel C. Modulation by L-type |
22 |
Liu PS, Liaw CT, Lin MK, Shin SH, Kao LS, Lin LF. Damphetamine enhances |
23 | Bouzat C. Ephedrine blocks wild-type and long-lived mutant acetylcholine receptor channels. Neuroreport 8: 317-321, 1996 DOI PUBMED ScienceOn |
24 | Schneider FH. D-amphetamine-induced exocytosis of catecholamines from the cow adrenal medulla. J Pharmacol Exp Ther 183: 80-89, 1972 PUBMED |
25 | Skau KA, Gerald MC. D-amphetamine inhibition of alpha-bungarotoxin binding at the mouse neuromuscular junction. Life Sci 20: 1495-1499, 1977 DOI PUBMED ScienceOn |
26 | Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A. D-amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15: 4102-4108, 1995 PUBMED |
27 |
Yamada Y, Teraoka H, Nakazato Y, Ohga A. Intracellular |
28 | Lim DY, Hwang DH. Studies on secretion of catecholamines evoked by DMPP and McN-A-343 in the rat adrenal gland. Korean J Pharmacol 27: 53-67, 1991 |
29 | Barrantes FJ, Antollini S, Massol R. Fluorescence studies of the nicotinic acetylcholine receptor in its membrane environment. Biosci Rep 19: 335-344, 1999 DOI ScienceOn |
30 | Chen Y, Ogren, SO, Bjelke B, Bolme P, Eneroth P, Gross J, Loidl F, Herrera-Marschitz M, Andersson K. Nicotine treatment counteracts perinatal asphyxia-induced changes in the mesotriatal/ limbic dopamine systems and in motor behaviour in the fourweek- old male rat. Neuroscience 68: 531-538, 199512693 DOI ScienceOn |
31 |
Misbahuddin M, Oka M. Muscarinic stimulation of guinea pig adrenal chromaffin cells stimulates catecholamine secetion without significant increase in |
32 | Mundorf ML, Hochstetler SE, Wightman RM. Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells. J Neurochem 73: 2397-2405, 1999 DOI PUBMED |
33 |
Hammer R, Giachetti A. Muscarinic receptor subtypes: |
34 | Milone M, Engel AG. Block of the endplate acetylcholine receptor channel by the sympathomimetic agents ephedrine, pseudoephedrine, and albuterol. Brain Res 740: 346-352, 1996 DOI PUBMED ScienceOn |
35 | Oka M, Isosaki M, Yanagihara N. Isolated bovine adrenal medullary cells: studies on regulation of catecholamine synthesis and release. In: Usdin E, Kopin IJ, Brachas J ed, Catecholamines: Basic and Clinical frontiers. Pergamon Press, Oxford, p 70-72, 1979 |
36 |
Andersen PH. Biochemical and pharmacological characterization of |
37 | Harish OE, Kao LS, Raffaniello R, Wakade AR, Shneider AS. Calcium dependence of muscarinic receptor-mediated catecholamine secretion from the perfused adrenal medulla. J Neurochem 48: 1730-1735, 1987 DOI PUBMED |
38 | Richter JA, Bare DJ, Yu H, Ghetti B, Simon JR. Dopamine transporter-dependent and independent endogenous dopamine release from weaver mouse striatum in vitro. J Neurochem 64: 191-198, 1995 DOI PUBMED ScienceOn |
39 | Garcia AG, Sala F, Reig JA, Viniegra S, Frias J, Fonteriz R, Gandia L. Dihydropyridine Bay-K-8644 activates chromaffin cell calcium channels. Nature 309: 69-71, 1984 DOI ScienceOn |
40 | Mercuri NB, Calabresi P, Bernardi G. The mechanism of damphetamine- induced inhibition of rat substantia nigra compacta neurones investigated with intracellular recording in vitro. Br J Pharmacol 98: 127-134, 1989 DOI PUBMED ScienceOn |
41 | Nakazato Y, Oleshanskly M, Tomita U, Yamada Y. Voltageindependent catecholamine release mediated by the activation of muscarinic receptors in guinea-pig adrenal glands. Br J Pharmacol 93: 101-109, 1988 DOI PUBMED ScienceOn |
42 | Dilger JP, Boguslavsky R, Barann M, Katz T, Vidal AM. Mechanisms of barbiturate inhibition of acetylcholine receptor channels. J Gen Physiol 109: 401-414. 1997 DOI ScienceOn |
43 | Challis RAJ, Jones JA, Owen PJ, Boarder MR. Changes in inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate mass accumulations in cultured adrenal chromaffin cells in response to bradykinin and histamine. J Neurochem 56: 1083-1086, 1991 DOI PUBMED |
44 |
Hurd YL, Ungerstedt U. |
45 | Kimura T, Shimamura T, Satoh S. Effects of pirenzepine and hexamethonium on adrenal catecholamine release in responses to endogenous and exogenous acetylcholine in anesthetized dogs. J Cardiovasc Pharmacol 20: 870-874, 1992 DOI PUBMED ScienceOn |
46 | Wayment H, Meiergerd SM, Schenk JO. Relationships between the catechol substrate binding site and d-amphetamine cocaine and mazindol binding sites in a kinetic model of the striatal transporter of dopamine in vitro. J Neurochem 70: 1941-1949, 1998 DOI PUBMED ScienceOn |
47 |
Bowyer JF, Masserano JM, Weiner N. Inhibitory effects of d-amphetamine on potassium-stimulated release of |
48 | Karler R, Calder LD, Bedingfield JB. A novel nicotiniccholinergic role in behavioral sensitization to d-amphetamine-induced stereotypy in mice. Brain Res 725: 192-198, 1996 DOI PUBMED |
49 | Spitzmaul GF, Esandi MC, Bouzat C. D-amphetamine acts as a channel blocker of the acetylcholine receptor. Neuroreport 10: 2175-2181, 1999 DOI PUBMED ScienceOn |
50 |
Suzuki M, Muraki K, Imaizumi Y, Watanabe M. Cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum |
51 | Wu X, Gu HH. Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue. Gene 233: 163-170, 1999 DOI PUBMED ScienceOn |
52 | Burnette WB, Bailey MD, Kukoyi S, Blakely RD, Trowbridge CG, Justice Jr JB. Human norepinephrine transporter kinetics using rotating disk electrode voltammetry. Anal Chem 68: 2932-2938, 1996 DOI ScienceOn |
53 | Lim DY, Kim CD, Ahn KW. Influence of TMB-8 on secretion of catecholamines from the perfused rat adrenal glands. Arch Pharm Res 15: 115-125, 1992 DOI ScienceOn |
54 | Burgoyne RD. Mechanism of secretion from adrenal chromaffin cells. Biochem Biophys Acta 779: 201-216, 1984 DOI ScienceOn |
55 | Raiteri M, Bertollini A, Angelini F, Levi G. Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J Pharmacol Exp Ther 208: 195-202, 1979 |
56 |
Seidler NW, Jona I, Vegh N, Martonosi A. Cyclopiazonic acid is a specific inhibitor of the |
57 | Sitte HH, Huck S, Reither H, Boehm S, Singer EA, Pifl C. Carrier-mediated release, transport rates, and charge transfer induced by d-amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 71: 1289-1297, 1998 DOI PUBMED ScienceOn |
58 |
Cheek TR, O'Sullivan AJ, Moreton RB, Berridge MJ, Burgoyne RD. Spatial localization of the stimulus-induced rise in cytosolic |
59 | Ilno M. Calcium-induced calcium release mechanism in guinea pig taenia caeci. J Gene Physiol 94: 363-383, 1989 DOI PUBMED ScienceOn |
60 | Amador M, Dani JA. MK-801 inhibition of nicotinic acetylcholine receptor channels. Synapse 7: 207-215, 1991 DOI ScienceOn |
61 | Pifl C, Agneter E, Drobny H, Sitte HH, Singer EA. D-amphetamine reverses or blocks the operation of the human noradrenaline transporter depending on its concentration: superfusion studies on transfected cells. Neuropharmacology 38: 157-165, 1999 DOI ScienceOn |
62 | Mahata M, Mahata SK, Parmer RJ, O'Connor DT. Vesicular monoamine transport inhibitors. Novel action at calcium channels to prevent catecholamine secretion. Hypertension 28: 414- 420, 1996 DOI PUBMED ScienceOn |
63 |
Uyama Y, Imaizumi Y, Watanabe M. Effects of cyclopiazonic acid, a novel |
64 | Pierce RC, Kalivas PW. Repeated cocaine modifies the mechanism by which d-amphetamine releases dopamine. J Neurosci 17: 3254-3262, 1997 PUBMED |
![]() |